Validation biomarkers segment is anticipated to dominate the market growth owing to the increasing demand for personalized medicine and targeted therapies. Efficacy biomarkers are also gaining traction due to their role in assessing treatment response and outcome prediction. Safety biomarkers are crucial for ensuring patient safety during drug development and clinical trials.
Biomarkers Market Analysis by Disease:
Neurological diseases segment is expected to witness significant growth due to the rising prevalence of conditions such as Alzheimer's and Parkinson's disease. Cancer biomarkers are also in high demand for early detection and personalized treatment. Immunological diseases, cardiovascular diseases, and other segments are also projected to experience growth owing to advancements in biomarker research.
Biomarkers Market Analysis by Application:
Personalized medicines segment is likely to drive market growth as biomarkers play a key role in selecting the most effective treatment for individual patients. Drug discovery and development applications of biomarkers are also growing rapidly, contributing to the overall market expansion. Diagnostics segment is crucial for early disease detection and monitoring, further fueling the demand for biomarkers.